Venture Capital Funds
|
|
DFJ ELEMENT, L.P. Element Venture Partners,, in partnership with Draper Fisher Jurvetson formed DFJ Element, L.P. with a target capitalization of $150 million to make venture capital investments primarily in clean technology. CleanTech sector offers a compelling opportunity for venture capital investment. The growing global economy is placing unprecedented demand on the world's resources, energy, power, water, air, and raw materials which in turn is challenging economic growth and profitability.
| |
 |
Conduit Ventures Limited (CVL) is the first EU venture capital company which specializes on fuel cells and related hydrogen technologies. We are the only firm with such a focus AND a global reach with investments currently in the United States, Canada, Germany, Japan and Great Britain.
Conduit Ventures II is being targeted as a €75M+ fund. Just as the first fund it will remain focused on the FC and Hydrogen. However, it will expand on the current fund’s abilities to access global research as well as markets. All of the original LPs are investing in the new fund as it will represent them with an opportunity to extend and expand their current exposure. New investors, including Shanghai Science & Technology Investment Corporation SSTIC, offer a multiple of strategic advantages to the fund. By way of access into the Chinese research capabilities, as well as manufacturing and marketing potential.
| |
 |
Zad Fund is a US $100 million fund focused on making regional and cross-border investments, mainly in growth and late stage companies across the information and communications technology industries. The fund is managed by Zad Capital Partners, a partnership between National Technology Enterprises Company, Riyada Ventures, and PrimeCrop. | |
|
|
Burrill & Company is the general partner of the Burrill Life Sciences Capital Fund III, L.P. (the "Fund"). This fund will be a life science focused venture capital fund, dedicated to investments in life science companies across the spectrum of sickness to wellness. BLSCF III will invest in companies at various stages of development, from seed and early stage to mezzanine levels, on a worldwide basis. The fund is capitalized at $300 million.
| |
 |
ePlanet Ventures is a Global Venture Capital Firm with 7 offices around the world, their investment strategy is diversified globally across ICT, LS and Energy sectors. | |
 |
Wellington Partners, formed in 1991, ranks among Europe's most successful early-stage investors. With € 500 million currently under management, the firm focuses on helping European entrepreneurs build companies with large global market opportunities, mostly in the areas of information technology, media convergence and life science.
To date, Wellington Partners has invested in over 85 companies, selling a third of them at a profit, in eight cases through an IPO. Serving as the lead or co-lead investor, Wellington Partners has already accompanied such successful start-ups as biotech company Actelion or openBC (XING) in their IPOs, and sold, among others, Grandis Biotech to Novartis, and the German auctioneer Alando to eBay///. | |
 |
Neuhaus Partners invests venture capital (VC) in companies from the information technology sector. Since its founding, the fund has led portfolio companies to several IPOs and numerous trade sales. Examples of former successful investments include ricardo.de, Nikoma, Eutex, NxN, handy.de and DocMorris.
| |
 |
CMEA Ventures is a venture capital firm with a clear focus on life sciences, high technology, and energy and materials investments. CMEA Ventures was founded in 1989 and has managed more than $1.1 Billion in capital commitments across six funds over the past eighteen years.
| |
